NR1H4 and intrahepatic cholestasis: Xue et al. (Wang X. et al., 2019) found that emodin inhibits Bsep by interfering with the interaction of 5’ adenosine monophosphate-activated protein kinase and farnesoid X receptor (Fxr) in the liver, thereby playing a role in promoting intrahepatic cholestasis.